Paul Edward Martin - 08 Aug 2025 Form 4 Insider Report for STERIS plc (STE)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
12 Aug 2025, 17:26:43 UTC
Prior SEC filing
11 Aug 2025
Next SEC filing
10 Nov 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ John P. Ubbing, Authorized Representative under Power of Attorney

Key filing fact

Paul Edward Martin filed Form 4 for STERIS plc (STE) on 12 Aug 2025.

Key facts

  • This page summarizes Paul Edward Martin's Form 4 filing for STERIS plc (STE).
  • 2 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 12 Aug 2025, 17:26.

Change

  • Previous filing in this sequence was filed on 11 Aug 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001700415 Primary reporting owner

Martin Paul Edward

Relationship
Director
Address
C/O 70 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, IRELAND
Signature
/s/ John P. Ubbing, Authorized Representative under Power of Attorney
Signature date
12 Aug 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

STE transaction Derivative

Director Stock Option (right to buy)

Award

Transaction value
$0
Shares
+1,407
Change %
Price
$0.000000
Shares after
1,407
Date
08 Aug 2025
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
1,407
Exercise price
$242.85
Footnotes
F1
STE transaction Derivative

Career Restricted Stock Units

Award

Transaction value
$0
Shares
+487
Change %
+12%
Price
$0.000000
Shares after
4,562
Date
08 Aug 2025
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
487
Exercise price
Footnotes
F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

These nonqualified stock options are fully vested and are exercisable immediately.

Footnote F2

Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service.

Footnote F3

These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .